| Financial Year |
March 31 2023 |
| Monetary Funds |
722,989,315.79 |
| Held-for-trading Financial Assets |
798,172,517.85 |
| Notes Receivable |
2,694,640.00 |
| Accounts Receivable |
249,030,033.25 |
| Advances to Suppliers |
37,787,494.48 |
| Other Receivables |
17,402,578.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,181,138,201.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
251,369,693.40 |
| Other Current Assets |
203,124,905.38 |
| Total Current Assets |
3,469,219,376.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
20,244,606.83 |
| Long-term Equity Investment |
2,680,168.22 |
| Investment Properties |
990,454.86 |
| Fixed Assetes |
377,049,821.66 |
| Under-construction Projects |
5,513,506.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
122,316,524.14 |
| R&D expenses |
8,507,445.84 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,464,439.59 |
| Deferred Income Tax Assets |
38,306,592.33 |
| Other Non-Current Assets |
16,589,409.53 |
| Sub-Total of Non-Current Assets |
1,026,935,617.10 |
| Total Assets |
4,496,154,993.90 |
| Short-Term Loans |
485,575,342.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
39,873,952.00 |
| Accounts Payable |
274,722,103.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,508,306.48 |
| Taxes Payable |
30,215,886.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
56,198,900.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,577,818.30 |
| Other Current Liabilities |
26,951,548.23 |
| Sub-Total of Current Liabilities |
1,960,206,878.94 |
| Long-term Loans |
-- |
| Bonds Payable |
669,987,742.44 |
| Long-Term Accounts Payable |
340,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,218,722.48 |
| Deferred Income Tax Liabilities |
8,234,036.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
752,783,584.60 |
| Total Liabilities |
2,712,990,463.54 |
| Paid-In Capital(Or Share Stock) |
658,654,404.00 |
| Capital Surplus |
188,245,059.42 |
| Surplus Reserve |
83,349,648.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
753,040,208.34 |
| Minority Stockholder's Interest |
2,904,009.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,780,260,521.19 |
| Owner's Equity（Stockholder's Equity） |
1,783,164,530.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,496,154,993.90 |
